Asymmetric cleavage of β-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses

被引:98
|
作者
Ziouzenkova, Ouliana
Orasanu, Gabriela
Sukhova, Galina
Lau, Evan
Berger, Joel P.
Tang, Guangwen
Krinsky, Norman I.
Dolnikowski, Gregory G.
Plutzky, Jorge
机构
[1] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[2] Merck Res Labs, Rahway, NJ USA
[3] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Medford, MA 02155 USA
[4] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
关键词
D O I
10.1210/me.2006-0225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
beta-Carotene and its metabolites exert a broad range of effects, in part by regulating transcriptional responses through specific nuclear receptor activation. Symmetric cleavage of beta-carotene can yield 9-cis retinoic acid (9-cisRA), the natural ligand for the nuclear receptor RXR, the obligate heterodimeric partner for numerous nuclear receptor family members. A significant portion of beta-carotene can also undergo asymmetric cleavage to yield apocarotenals, a series of poorly understood naturally occurring molecules whose biologic role, including their transcriptional effects, remains essentially unknown. We show here that beta-apo-14'-carotenal (apo14), but not other structurally related apocarotenals, represses peroxisome proliferator-activated receptors (PPAR) and RXR activation and biologic responses induced by their respective agonists both in vitro and in vivo. During adipocyte differentiation, apo14 inhibited PPAR gamma target gene expression and adipogenesis, even in the presence of the potent PPAR gamma agonist BRL49653. Apo14 also suppressed known PPAR alpha responses, including target gene expression and its known antiinflammatory effects, but not if PPAR alpha agonist stimulation occurred before apo14 exposure and not in PPAR alpha-deficient cells or mice. Other apocarotenals tested had none of these effects. These data extend current views of beta-carotene metabolism to include specific apocarotenals as possible biologically active mediators and identify apo14 as a possible template for designing PPAR and RXR modulators and better understanding modulation of nuclear receptor activation. These results also suggest a novel model of molecular endocrinology in which metabolism of a parent compound, beta-carotene, may alternatively activate (9-cisRA) or inhibit (apo14) specific nuclear receptor responses.
引用
收藏
页码:77 / 88
页数:12
相关论文
共 50 条
  • [31] Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor
    Yagai, Tomoki
    Nakamura, Takahisa
    FRONTIERS IN MEDICINE, 2022, 9
  • [32] Transcriptional Regulation of the Peroxisome Proliferator-Activated Receptor γ Coactivator-1α
    Ramjiawan, Angela
    Czubryt, Michael P.
    CIRCULATION, 2009, 120 (18) : S894 - S895
  • [33] Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor γ/retinoid X receptor α pathway
    Tsujie, M
    Nakamori, S
    Okami, J
    Takahashi, Y
    Hayashi, N
    Nagano, H
    Dono, K
    Umeshita, K
    Sakon, M
    Monden, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (02) : 325 - 331
  • [34] Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
    Tontonoz, P
    Singer, S
    Forman, BM
    Sarraf, P
    Fletcher, JA
    Fletcher, CDM
    Brun, RP
    Mueller, E
    Altiok, S
    Oppenheim, H
    Evans, RM
    Spiegelman, BM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (01) : 237 - 241
  • [35] A peroxisome proliferator-activated receptor γ-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription
    Kraetzner, Ralph
    Froehlich, Florian
    Lepler, Katrin
    Schroeder, Michaela
    Roeher, Katharina
    Dickel, Corinna
    Tzvetkov, Mladen V.
    Quentin, Thomas
    Oetjen, Elke
    Knepel, Willhart
    MOLECULAR PHARMACOLOGY, 2008, 73 (02) : 509 - 517
  • [36] Agonists for the peroxisome proliferator-activated receptor-α and the retffionid X receptor inhibit inflammatory responses of microglia
    Xu, JH
    Storer, PD
    Chavis, JA
    Racke, MK
    Drew, PD
    JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 81 (03) : 403 - 411
  • [37] Peroxisome Proliferator-Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease
    Mello, Tommaso
    Polvani, Simone
    Galli, Andrea
    PPAR RESEARCH, 2009, 2009
  • [38] Peroxisome proliferator-activated receptor α-independent peroxisome proliferation
    Zhang, Xiuguo
    Tanaka, Naoki
    Nakajuna, Takero
    Kamijo, Yuji
    Gonzalez, Frank J.
    Aoyama, Toshifumi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 346 (04) : 1307 - 1311
  • [39] Retinoid X receptor-γ and peroxisome proliferator-activated receptor-γ expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment
    Klopper, JP
    Hays, WR
    Sharma, V
    Baumbusch, MA
    Hershman, JM
    Haugen, BR
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (08) : 1011 - 1020
  • [40] Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells
    Wang, D.
    Ning, W.
    Xie, D.
    Guo, L.
    DuBois, R. N.
    ONCOGENE, 2012, 31 (08) : 1013 - 1023